Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Julien Taı̈eb(Université Paris Cité), Josep Tabernero(Vall d'Hebron Hospital Universitari), Enrico Mini(University of Florence), Fabien Subtil(Hospices Civils de Lyon), Gunnar Folprecht(University Hospital Carl Gustav Carus), Jean-Luc Van Laethem(Erasmus Hospital), J. Thaler(Barmherzige Schwestern vom heiligen Kreuz), John Bridgewater(University College London), Lone Nørgård Pétersen(Rigshospitalet), Hélène Blons(Inserm), Laurence Collette(European Organisation for Research and Treatment of Cancer), Eric Van Cutsem(KU Leuven), Philippe Rougier(Université Paris Cité), Ramón Salazar(Institut d'Investigació Biomédica de Bellvitge), Laurent Bedenne(Maison des Sciences de l’Homme de Dijon), Jean‐François Emile(Hôpital Ambroise-Paré), Pierre Laurent‐Puig(Sorbonne Paris Cité), Côme Lepage(Maison des Sciences de l’Homme de Dijon)
Cited by 284Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis